インシュリン依存性糖尿病（ＩＤＤＭ）患者に作用する免疫反応および免疫治療分子 - アムラド・オペレイションズ・プロプライエタリー・リミテッド

Title:

インシュリン依存性糖尿病（ＩＤＤＭ）患者に作用する免疫反応および免疫治療分子

Document Type and Number:

Japanese Patent JPH11500719

Kind Code:

A

Abstract:

The present invention relates generally to molecules such as peptides, polypeptides and proteins which interact immunologically with antibodies or T-cells in subjects having pre-clinical or clinical Insulin-Dependent Diabetes Mellitus (IDDM). These molecules are preferentially immunoreactive to T-cells in subjects having pre-clinical or clinical IDDM and are useful in the development of diagnostic, therapeutic and prophylactic agents for IDDM.

More Like This:

WO/1997/008320	PROTEIN/(POLY)PEPTIDE LIBRARIES
WO/2003/023061	READING, DETECTION OR QUANTIFICATION METHOD, HYBRIDS OR COMPLEXES USED IN SAID METHOD AND THE BIOCHIP USING SAME
WO/2002/057739	COMPOSITION AND METHODS FOR SYNTHESIS OF NOVEL TRACERS FOR DETECTING AMPHETAMINE AND METHAMPHETAMINE IN SAMPLES

Inventors:

ハニーマン，マーゴ
ハリソン，レナード
ルー，アンドリュー
ルーディ，ジョージ

Application Number:

JP52523896A

Publication Date:

January 19, 1999

Filing Date:

February 20, 1996

Export Citation:

Click for automatic bibliography generation Help

Assignee:

アムラド・オペレイションズ・プロプライエタリー・リミテッド

International Classes:

G01N33/53; A61K38/00; A61P3/08; A61P3/10; C07K7/08; C07K14/47; C07K14/62; C12N9/88; C12Q1/02; G01N33/564; G01N33/74; (IPC1-7): C07K7/08; A61K38/00; C07K14/47; C12Q1/02; G01N33/53; G01N33/564

Attorney, Agent or Firm:

青山葆（外２名）

Previous Patent: キラル化合物

Next Patent: カチオンブリッジを有するメタロセン錯体